Clinical Trial: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access

Official Title: An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Brief Summary: Provide patients with serious AdV infection or disease access to treatment with BCV.

Detailed Summary:
Sponsor: Chimerix

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Chimerix

Dates:
Date Received: November 3, 2015
Date Started:
Date Completion:
Last Updated: December 7, 2016
Last Verified: December 2016